AVRICORE HEALTH INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.155 CAD | -8.82% |
|
0.00% | -8.82% |
| 30/04 | Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04/04 | Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 17.68L 12.94L 11Cr | Sales 2023 | 34.85L 25.51L 21Cr | Capitalization | 1.69Cr 1.24Cr 103.4Cr |
|---|---|---|---|---|---|
| Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | 17.3 x |
| Net cash position 2022 | 6L 4L 3.6Cr | Net cash position 2023 | 2L 2L 1.51Cr | EV / Sales 2023 | 4.79 x |
| P/E ratio 2022 |
-37.7
x | P/E ratio 2023 |
-24.1
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.31% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -8.82% | ||
| 1 month | +14.81% | ||
| 3 months | +14.81% | ||
| 6 months | -11.43% | ||
| Current year | -8.82% |
1 week
0.16
0.17
1 month
0.130.17
Current year
0.110.18
1 year
0.110.30
3 years
0.080.41
5 years
0.000.69
10 years
0.003.76
| Managers | Title | Age | Since |
|---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 01/19/01 |
Kiki Smith
DFI | Director of Finance/CFO | - | 06/19/06 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08/20/08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Hall
CHM | Chairman | 71 | 20/16/20 |
Robert Sindelar
BRD | Director/Board Member | 71 | 27/18/27 |
Christine Hrudka
BRD | Director/Board Member | - | 21/23/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 0.155 | -8.82% | 142,500 |
| 09/24/09 | 0.17 | +3.03% | 2,000 |
| 08/24/08 | 0.165 | 0.00% | 18,600 |
| 07/24/07 | 0.165 | 0.00% | 35,062 |
| 06/24/06 | 0.165 | +6.45% | 178,500 |
Delayed Quote Toronto S.E., May 11, 2024 at 01:29 am IST
More quotes
Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.
Sector
Pharmaceuticals
Calendar
29/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -8.82% | 1.13Cr | |
| +29.30% | 68TCr | |
| +29.44% | 57TCr | |
| -3.97% | 36TCr | |
| +18.48% | 33TCr | |
| +4.58% | 28TCr | |
| +15.90% | 24TCr | |
| +9.33% | 21TCr | |
| -7.16% | 20TCr | |
| +7.70% | 17TCr |
- Stock Market
- Equities
- AVCR Stock
